SEC Form 4 · accession 0001179110-18-007255
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Meury
Officer — EVP & Chief Commercial Officer
Period of report
May 17, 2018
Accepted (ET)
May 21, 2018 · 5:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001F1,F2 | May 17, 2018 | M | 1,467 | $68.11 | A | 20,369 | D | |
| Ordinary Shares, par value $0.0001F1,F2 | May 17, 2018 | M | 19,785 | $68.11 | A | 40,154 | D | |
| Ordinary Shares, par value $0.0001F3,F2 | May 17, 2018 | S | 24,425 | $154.59 | D | 15,729 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock OptionF4 | $68.11 | May 17, 2018 | M | 1,467 | D | — | Dec 5, 2018 | Ordinary Shares | 1,467 | 0 | D |
| Non-Qualified Options to Purchase Common StockF5 | $68.11 | May 17, 2018 | M | 19,785 | D | — | Dec 5, 2018 | Ordinary Shares | 19,785 | 0 | D |
Explanation of responses
- F1This exercise is pursuant to a previously established 10b5-1 Trading Plan dated November 16, 2017 for the Reporting Person.
- F2Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
- F3This sale is pursuant to a previously established 10b5-1 Trading Plan dated November 16, 2017 for the Reporting Person.
- F4The options vested on December 6, 2015.
- F5The options vested in five equal installments on December 6, 2011, 2012, 2013, 2014 and 2015.